Bioavalibality and bioequivalance in pharmaceutical technology
By: Kumar, Pal Tapan.
Contributor(s): Genesan, M.
Publisher: Pune 2004Edition: 1st.Description: 159, 24.9*19.1 Pages | Binding - Paperback |.ISBN: 81-239-1158-9.Subject(s): PHARMACEUTICSDDC classification: 615.19 Online resources: Click here to access online Summary: This book deals with the ethical issues involved in bioequivalence study as per DCGI (Drug Controller General of India, New Delhi) as well as FDA guidelines. The concept of bioavailability and its study methodology in human volunteers have been discussed in detail with a special emphasis on protocol preparation, volunteer screening, informed consent, inclusion and exclusion criteria and study of pathological parameters prior to undertaking any bioequivalence study. Various methods of sample preparation and extraction of drug from plasma have been illustrated by different methods. The sophisticated techniques of solid phase extraction (SPE) system have been proved to be most simple, sensitive and time-saving. The different dimensions of its application and procedures have been highlighted. The procedures for evaluation of pharmacokinetic parameters and their interpretation have been illustrated with methodical approach. The application of microdialysis in bioavailability study as well as ocular kinetics and drug delivery system of ophthalmic medicines have also been discussed in this book.Item type | Current location | Collection | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|---|---|
Text Books | School of Pharmacy Reference Section | Reference | 615.19 KUM/GEN (Browse shelf) | Available | B0637 | ||
Text Books | School of Pharmacy General Stacks | Circulation | 615.19 KUM/GEN (Browse shelf) | Available | B0638 |
Browsing School of Pharmacy Shelves , Shelving location: General Stacks , Collection code: Circulation Close shelf browser
No cover image available | No cover image available | |||||||
615.19 KUL/BOT Drug design | 615.19 KUL/BOT Drug design | 615.19 KUL/BOT Drug design | 615.19 KUM/GEN Bioavalibality and bioequivalance in pharmaceutical technology | 615.19 KUM/MUR Pharmaceutical chemistry-I | 615.19 LAD/MAN Fundamental of drug metabolism and drug disposition | 615.19 LAD/MAN Fundamental of drug metabolism and drug disposition |
This book deals with the ethical issues involved in bioequivalence study as per DCGI (Drug Controller General of India, New Delhi) as well as FDA guidelines. The concept of bioavailability and its study methodology in human volunteers have been discussed in detail with a special emphasis on protocol preparation, volunteer screening, informed consent, inclusion and exclusion criteria and study of pathological parameters prior to undertaking any bioequivalence study. Various methods of sample preparation and extraction of drug from plasma have been illustrated by different methods. The sophisticated techniques of solid phase extraction (SPE) system have been proved to be most simple, sensitive and time-saving. The different dimensions of its application and procedures have been highlighted. The procedures for evaluation of pharmacokinetic parameters and their interpretation have been illustrated with methodical approach. The application of microdialysis in bioavailability study as well as ocular kinetics and drug delivery system of ophthalmic medicines have also been discussed in this book.
There are no comments for this item.